CNE 202: Children's Oncology Group Nursing Educational Track - Clinical Trials Pediatric Oncology Nursing
The Children's Oncology Group Nursing Educational Track is online continuing education in individual modules that aims to educate and disseminate information relative to clinical trials to pediatric oncology nurses and set the standard of excellence for the care of children and adolescents with cancer treated on COG clinical trials.
This course is offered as one course with 4 modules, or four courses with 1 module.
Nurses, specialty nurses, healthcare providers, and APRNs. Learners should have knowledge of pediatric oncology practice.
In support of improving patient care, the University of Minnesota, Interprofessional Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This course is awarded up to 4.0 ANCC contact hours or each module is awarded 1.0 ANCC contact hour.
Other Health Professionals: It is the responsibility of each participant to determine if the program meets the criteria for re-licensure or re-certification for their discipline. Each participant will receive an Evidence of Participation document. Please check with your accrediting organization for complete requirements.
Successful Completion of Course
Participants must have completed the following:
- Accessed and completed the content found in each module.
- Passed each quiz with at least 80%.
- Completed each module evaluation.
- Completed the course evaluation.
Full Course Registration: $80
Single Module Registration: $25
Cancellation Policy: A course registration may be canceled by emailing the School of Nursing Office of Continuing Professional Development at email@example.com. No refunds will be granted once the Moolde course has been accessed.
Sue Zupanec, RN, MSN
Wendy Landier, PhD, RN, CPNP, CPON
Molly Brickler, RN, MS, APNP-AC and Christina Schulta, RN, MS, APNP-PC
Maureen Haugen, MS, CPNP, CPON and Barbara Lockart, DNP, CPNP, CPON
Lyn Limoges, BScN, RN AND Anne Marie Maloney, MSN, NP, CPHON
Amy Newman, RN, MSN, CPNP-PC and Stacy Whiteside, APRN, MS, CPNP-AC, CPON
Learning Objectives & Syllabus
Learning Objectives & Syllabus
Upon completion of this course, learners should be able to:
- Describe nursing assessments and interventions for pediatric cancer patients receiving new protocol-based therapies.
- Identify strategies for supporting patients and families after completing treatment in receiving comprehensive follow up care and information.
- Identify nursing strategies for promoting adherence to cancer treatment.
Module A - Demystifying COG ANHL 1131: An Intergroup Clinical Trial to Treat High Risk B-Cell Malignancies
- Review the advancements in treatment of children and adolescents with HR B-cell malignancies.
- Explain the risk stratification of patients on COG ANHL 1131.
- Describe the role of MoAb therapy in the treatment of patients with HR B-cell malignancies.
- Discuss the challenges of providing care for patients with HR B-cell malignancies.
Module B - Ph+ and Ph-like ALL: Evolution of New Treatments Through COG Clinical Trials
- Describe Ph+ ALL in children, adolescents, and young adults, including incidence, clinical features, evolving treatment, and prognosis.
- Describe the clinical course of Ph-like ALL and the newly available laboratory testing that can identify potentially targetable lesions.
- Discuss the COG clinical trials that test TKIs (imatinib and dasatinib) in pateitnts with Ph+ ALL.
Module C - Pediatric Bone Tumors: Meeting the Challenges through COG Clinical Trials
- Describe the therapeutic approach to the management of pediatric bone tumors.
- Identify ongoing challenges in the management of pediatric bone tumors.
- List 3 agents under investigation in the treatment of pediatric bone tumors.
Module D - Radiation Therapy: Lessons from COG Clinical Trials
- Discuss the indications for radiation therapy oncology, as well as its short-term and long-term effects.
- Describe the evolution of radiation therapy as a treatment modality utilized in COG clinical trials.